A Practical Perspective of the Hematologic Manifestations of Systemic Lupus Erythematosus

Area of Science:

• Rheumatology
• Hematology
• Internal Medicine

Background:

• Systemic lupus erythematosus (SLE) is a chronic, multisystem inflammatory disease of unknown etiology.
• Hematologic manifestations are common in SLE, often presenting early and impacting patient morbidity.
• These blood-related issues necessitate aggressive treatment with high-dose immunosuppressants.

Purpose of the Study:

• To comprehensively review the hematologic manifestations of SLE.
• To provide clinicians with a practical guide for diagnosing and treating these conditions.
• To highlight the diagnostic challenges, such as initial misclassification of conditions like hemolytic anemia and immune thrombocytopenia.

Main Methods:

• Literature review focusing on hematologic manifestations in SLE.
• Analysis of the spectrum of hematologic alterations in SLE patients.
• Discussion of diagnostic criteria and therapeutic approaches for SLE-related hematologic conditions.

Main Results:

• The spectrum of hematologic manifestations in SLE is broad, including lymphopenia, anemia, thrombocytopenia, and pancytopenia.
• Hematologic involvement often predominates in the early years of SLE and can be the initial presentation.
• Conditions like hemolytic anemia and immune thrombocytopenia may initially be misdiagnosed as idiopathic before being linked to SLE.

Conclusions:

• Hematologic manifestations are a significant feature of SLE, frequently indicating high disease activity.
• A multifactorial understanding of these alterations is crucial for comprehensive therapeutic strategies.
• This review aims to enhance clinical understanding and management of SLE-associated hematologic disorders.